No Prescription |
 |
 | ||
|
ADMENTA NAMENDA |
|
| ||
No Prescription » Prescription Drugs 1 » ADMENTA NAMENDA Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain. Memantine can help people with Alzheimer's disease to think more clearly and perform daily activities more easily but it is not a cure and does not stop the progression of the disease.Memantine comes as a tablet to take by mouth. It is usually taken once or twice a day with or without food. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. To help you remember to take memantine take it at around the same time(s) every day. Take memantine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Your doctor will probably start you on a low dose of memantine and gradually increase your dose not more than once every week.Memantine controls Alzheimer's disease but does not cure it. Continue to take memantine even if you feel well. Do not stop taking memantine without talking to your doctor. Buy ADMENTA NAMENDA and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About ADMENTA NAMENDA: Product Type: Prescription Drugs 1 ADMENTA ( NAMENDA Generic Memantine ) ADMENTA (NAMENDA Generic Memantine) NAMENDA Generic Memantine 10MG 100( 2 x 50 )Tablets 10MG 200 (4 x 50) Tablets 10MG. 50 Tablets 5mg 50 Tablets 5mg 200 (4 x 50) Tablets 5mg 100 (2 x 50) Tablets NAMENDA Generic Memantine ADMENTA
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
